BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24875532)

  • 1. Decreased CD34+ cell number is correlated with cardiac dysfunction in patients with acute exacerbation of COPD.
    Liu Y; Liu X; Lin G; Sun L; Li H; Xie C
    Heart Lung Circ; 2014 Sep; 23(9):875-82. PubMed ID: 24875532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease: diagnostic performance of cardiac biomarkers.
    Abroug F; Ouanes-Besbes L; Nciri N; Sellami N; Addad F; Hamda KB; Amor AB; Najjar MF; Knani J
    Am J Respir Crit Care Med; 2006 Nov; 174(9):990-6. PubMed ID: 16840745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal proB-type natriuretic peptide levels aid the diagnosis of left ventricular dysfunction in patients with severe acute exacerbations of chronic obstructive pulmonary disease and renal dysfunction.
    Ouanes I; Jalloul F; Ayed S; Dachraoui F; Ouanes-Besbes L; Fekih Hassen M; Elatrous S; Abroug F
    Respirology; 2012 May; 17(4):660-6. PubMed ID: 22348741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of nasal intermittent positive pressure ventilation on N-terminal pro-brain natriuretic peptide in patients with acute exacerbations of chronic obstructive pulmonary disease and type II respiratory failure].
    Wang Y; Yang Y; Chen P; Luo Y; Yang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Apr; 37(4):325-31. PubMed ID: 22561561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of NT-proBNP in vascular surgery patients with COPD and normal left ventricular systolic function.
    van Gestel YR; Goei D; Hoeks SE; Sin DD; Flu WJ; Stam H; Mertens FW; Bax JJ; van Domburg RT; Poldermans D
    COPD; 2010 Feb; 7(1):70-5. PubMed ID: 20214466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma N-terminal pro-brain natriuretic peptide: a prognostic marker in patients with chronic obstructive pulmonary disease.
    Chi SY; Kim EY; Ban HJ; Oh IJ; Kwon YS; Kim KS; Kim YI; Kim YC; Lim SC
    Lung; 2012 Jun; 190(3):271-6. PubMed ID: 22246552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in biomarkers in patients with heart failure with a reduced vs a preserved left ventricular ejection fraction.
    de Denus S; Lavoie J; Ducharme A; O'Meara E; Racine N; Sirois MG; Neagoe PE; Zhu L; Rouleau JL; White M
    Can J Cardiol; 2012; 28(1):62-8. PubMed ID: 22104539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of right ventricular dysfunction on exercise capacity and quality of life and associations with serum NT-proBNP levels in COPD: an observational study.
    Ozdemirel TS; Ulaşli SS; Yetiş B; Karaçağlar E; Bayraktar N; Ulubay G
    Anadolu Kardiyol Derg; 2014 Jun; 14(4):370-7. PubMed ID: 24818627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of combined detection of N-terminal pro-B-type natriuretic peptide and left ventricular ejection fraction in heart function in patients with acute CO poisoning.
    Liu SD; Shen Q; Lv C; Zhang P; Yu H; Yang L; Wu L
    Am J Emerg Med; 2014 Oct; 32(10):1212-4. PubMed ID: 25151325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation among the levels of C-reactive protein and interleukin-18, quality of life, and lung function in patients with chronic obstructive pulmonary disease].
    Long H; Luo H; Chen P; Li Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1090-6. PubMed ID: 22169727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in plasma levels of B-type natriuretic peptide with acute exacerbations of chronic obstructive pulmonary disease.
    Nishimura K; Nishimura T; Onishi K; Oga T; Hasegawa Y; Jones PW
    Int J Chron Obstruct Pulmon Dis; 2014; 9():155-62. PubMed ID: 24523584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of N-terminal pro-brain natriuretic peptide to detect acute cardiac dysfunction during weaning failure in difficult-to-wean patients with chronic obstructive pulmonary disease.
    Grasso S; Leone A; De Michele M; Anaclerio R; Cafarelli A; Ancona G; Stripoli T; Bruno F; Pugliese P; Dambrosio M; Dalfino L; Di Serio F; Fiore T
    Crit Care Med; 2007 Jan; 35(1):96-105. PubMed ID: 17095948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobilization of CD34(+), CD117(+), CXCR4(+), c-met(+) stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients with acute myocardial infarction.
    Wojakowski W; Tendera M; Zebzda A; Michalowska A; Majka M; Kucia M; Maslankiewicz K; Wyderka R; Król M; Ochala A; Kozakiewicz K; Ratajczak MZ
    Eur Heart J; 2006 Feb; 27(3):283-9. PubMed ID: 16267071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-terminal pro-brain natriuretic protein levels in takotsubo cardiomyopathy.
    Nguyen TH; Neil CJ; Sverdlov AL; Mahadavan G; Chirkov YY; Kucia AM; Stansborough J; Beltrame JF; Selvanayagam JB; Zeitz CJ; Struthers AD; Frenneaux MP; Horowitz JD
    Am J Cardiol; 2011 Nov; 108(9):1316-21. PubMed ID: 21871590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M; Bozkurt A; Yildiray-Sahin D; Unal I; Acartürk E
    Cardiol J; 2009; 16(1):43-9. PubMed ID: 19130415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension.
    Blyth KG; Groenning BA; Mark PB; Martin TN; Foster JE; Steedman T; Morton JJ; Dargie HJ; Peacock AJ
    Eur Respir J; 2007 Apr; 29(4):737-44. PubMed ID: 17135228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.
    Andrijevic L; Milutinov S; Andrijevic I; Jokic D; Vukoja M
    Balkan Med J; 2017 May; 34(3):226-231. PubMed ID: 28443567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort.
    Dong SJ; de las Fuentes L; Brown AL; Waggoner AD; Ewald GA; Dávila-Román VG
    J Am Soc Echocardiogr; 2006 Aug; 19(8):1017-25. PubMed ID: 16880097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.